Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation
Kachroo, S., Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Kuznik, A., Mardekian, J., Liu, X., Lawrence, J., Lip, G.Y.Volume:
17
Langue:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.03.661
Date:
May, 2014
Fichier:
PDF, 65 KB
english, 2014
File converter
Plus de résultats de recherche
More benefits 
